NEW YORK, NY / ACCESSWIRE / May 18, 2020 / Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.
Stemline Therapeutics, Inc. (STML)
Merger Announcement: May 4, 2020
Transaction Details: Under the terms of the agreement, a wholly owned subsidiary of the Menarini Group will commence a tender offer for all outstanding shares of Stemline, whereby Stemline shareholders will be offered $11.50 in cash and one non-tradeable contingent value right.
To learn more about the STML investigation and your rights, go to:
Portola Pharmaceuticals, Inc. (PTLA)
Merger Announcement: May 5, 2020
Transaction Details: Under the terms of the merger, a subsidiary of Alexion will commence a tender offer to acquire all of the outstanding shares of Portola's common stock at a price of $18 per share in cash.
To learn more about the PTLA investigation and your rights, go to:
Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP